Recombinant Human SDF1 Protein，His

SDF1 (Stromal Derived Factor 1) is a chemokine that plays a critical role in cellular processes such as immune response, hematopoiesis, and angiogenesis. It primarily functions by guiding the migration and homing of various cell types, including stem cells and immune cells, to specific tissues during development and in response to injury or inflammation. Given its significant role in these biological processes, SDF1 has gained attention in therapeutic research, particularly in the fields of regenerative medicine and cancer treatment. Recombinant SDF1 proteins have been developed to study their effects on cell migration and differentiation, as well as to investigate their potential applications in promoting tissue repair and modulating immune responses. Researchers are exploring SDF1's interactions with its receptor, CXCR4, to better understand the underlying mechanisms of diseases such as cancer metastasis and HIV infection. By producing and characterizing recombinant SDF1, scientists aim to uncover new strategies for using this protein in clinical applications, including enhancing stem cell therapy, improving wound healing, and developing targeted cancer therapies. The ongoing research into SDF1 recombination not only provides insights into fundamental biological processes but also holds promise for innovative therapeutic approaches to address a variety of health challenges.